|
WO2000044722A1
(en)
|
1999-01-29 |
2000-08-03 |
Chugai Seiyaku Kabushiki Kaisha |
Chondrongenesis promotors and indolin-2-one derivatives
|
|
US20040138285A1
(en)
|
2001-04-27 |
2004-07-15 |
Makoto Okazaki |
Chondrogenesis promoters
|
|
US6514989B1
(en)
|
2001-07-20 |
2003-02-04 |
Hoffmann-La Roche Inc. |
Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
|
|
JPWO2004039816A1
(ja)
|
2002-10-29 |
2006-03-02 |
塩野義製薬株式会社 |
セフェム化合物の無機酸塩の結晶
|
|
CA2515190A1
(en)
|
2003-02-14 |
2004-08-26 |
Pfizer Products Inc. |
Triazolo-pyridines as anti-inflammatory compounds
|
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
|
US20070004658A1
(en)
|
2004-06-21 |
2007-01-04 |
Nick Vandeghinste |
Method and means for treatment of osteoarthritis
|
|
EP1786811A2
(en)
|
2004-08-18 |
2007-05-23 |
Pharmacia & Upjohn Company LLC |
Triazolopyridine compounds
|
|
WO2006038116A2
(en)
|
2004-10-07 |
2006-04-13 |
Warner-Lambert Company Llc |
Triazolopyridine derivatives as antibacterial agents
|
|
GB0515026D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
|
JP5336375B2
(ja)
|
2006-08-30 |
2013-11-06 |
セルゾーム リミテッド |
キナーゼ阻害剤としてのトリアゾール誘導体
|
|
CL2008001626A1
(es)
|
2007-06-05 |
2009-06-05 |
Takeda Pharmaceuticals Co |
Compuestos derivados de heterociclos fusionados, agente farmaceutico que los comprende y su uso en la profilaxis y tratamiento del cancer.
|
|
US8053574B2
(en)
|
2007-07-18 |
2011-11-08 |
Novartis Ag |
Organic compounds
|
|
WO2009017954A1
(en)
|
2007-08-01 |
2009-02-05 |
Phenomix Corporation |
Inhibitors of jak2 kinase
|
|
CA2691448A1
(en)
|
2007-08-31 |
2009-03-05 |
Dominique Swinnen |
Triazolopyridine compounds and their use as ask inhibitors
|
|
GB0719803D0
(en)
|
2007-10-10 |
2007-11-21 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
BRPI0909945A2
(pt)
|
2008-06-20 |
2015-07-28 |
Genentech Inc |
"composto, composição farmacêutica, método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak2 quinase em um paciente, kit para o tratamento de uma doença ou distúrbio responsivo à inibição da jak quinase"
|
|
WO2010010189A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
WO2010010188A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases.
|
|
WO2010010186A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
WO2010010184A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
[1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors
|
|
WO2010010187A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
WO2010013768A1
(ja)
|
2008-07-31 |
2010-02-04 |
第一三共株式会社 |
チアゾリジンジオン化合物の結晶及びその製造方法
|
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
|
JP2013049632A
(ja)
|
2011-08-30 |
2013-03-14 |
Kowa Co |
ベンゾチアジン化合物のモノマレイン酸塩を有効成分とするアレルギー疾患の予防及び／又は治療剤
|
|
SA112330992B1
(ar)
|
2011-11-10 |
2015-09-13 |
كيورين فارماسوتيكال كو.، ليمتد |
صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
|
|
US20130310340A1
(en)
|
2012-05-16 |
2013-11-21 |
Rigel Pharmaceuticals, Inc. |
Method of treating muscular degradation
|
|
AU2013279597B2
(en)
|
2012-06-22 |
2017-04-20 |
Alfasigma S.P.A. |
Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
|
|
GB201402070D0
(en)
|
2014-02-07 |
2014-03-26 |
Galapagos Nv |
Pharmaceutical compositions for the treatment of inflammatory disorders
|
|
GB201402071D0
(en)
|
2014-02-07 |
2014-03-26 |
Galapagos Nv |
Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
CA2982630A1
(en)
*
|
2015-04-13 |
2016-10-20 |
Galapagos Nv |
Methods for the treatment of inflammatory disorders
|
|
RS64677B1
(sr)
|
2015-04-13 |
2023-11-30 |
Galapagos Nv |
Metode lečenja kardiovaskularnih poremećaja
|
|
US20170173034A1
(en)
*
|
2015-12-17 |
2017-06-22 |
Gilead Sciences, Inc. |
Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders
|
|
PL3595667T3
(pl)
*
|
2017-03-14 |
2024-03-18 |
Galapagos Nv |
Kompozycje farmaceutyczne zawierające inhibitor jak
|